Food And Drug Administration panel advises very very first cannabis-derived epilepsy medication

Food And Drug Administration panel advises very very first cannabis-derived epilepsy medication

a prescription that is new manufactured by UK-based GW Pharmaceuticals PLC could be the very first prescription that is cannabis-based become authorized by the usa Food and Drug Management.

A food and drug administration panel that is advisory the agency’s approval for the cannabis-derived Epidiolex for the treating unusual types of epilepsy. The committee voted 13-0 meant for Epidiolex after determining that the drug’s risk-benefit profile had been favorable.

Epidiolex is a purified formulation of cannabidiol or CBD, that will be utilized in the treating Dravet syndrome and syndrome that is lennox-Gastaut clients aged 2 yrs old and above. Continue reading “Food And Drug Administration panel advises very very first cannabis-derived epilepsy medication”